The National Cancers Institute defines AML as a quickly progressing disease in which too many immature white bloodstream cells are located in the bloodstream and bone marrow. In 2008, the American Cancer Society’s Cancer Information and Figures estimates 13,290 new situations of AML and 8,820 deaths.. Celator Pharmaceuticals enrols first patient in phase 2 study of CPX-351 in acute myeloid leukemia Celator Pharmaceuticals today announced that the first patient has been treated in a randomized Phase 2 clinical study of CPX-351 Liposome Injection in patients with newly diagnosed acute myeloid leukemia . The first patient was enrolled by Eric Feldman, MD at the Weill Medical University of Cornell New and University York Presbyterian Hospital.The researchers found that currently 57.7 percent of all people who have dementia worldwide reside in low and middle class countries, which is projected to rise to 70.5 percent by 2050. Growth in dementia over another 20 years will be much steeper in low and middle compared with high income countries. The record forecasts a 40 percent increase in numbers in Europe, 63 percent in THE UNITED STATES, 77 percent in the southern Latin American cone and 89 percent in the made Asia Pacific countries. These statistics are to be weighed against 117 percent growth in East Asia, 107 percent in South Asia, 134-146 percent in the rest of Latin America, and 125 percent in North Africa and the center East.